Sclerosing Dermatofibrosarcoma Protuberans: A Possible Diagnosis When a Small Biopsy Shows Sclerotic Fibroma-Like Features.


Journal

The American Journal of dermatopathology
ISSN: 1533-0311
Titre abrégé: Am J Dermatopathol
Pays: United States
ID NLM: 7911005

Informations de publication

Date de publication:
01 Oct 2024
Historique:
medline: 19 9 2024
pubmed: 19 9 2024
entrez: 18 9 2024
Statut: ppublish

Résumé

Dermatofibrosarcoma protuberans (DFSP) is a neoplasm of intermediate malignancy with high local recurrence rates. The sclerosing variant is characterized by the presence of sclerotic areas in more than 50% of tumors and is rarely reported. In this report, we describe a case of sclerosing DFSP with areas histopathologically resembling sclerotic fibroma, where the initial biopsy tissue presented a diagnostic challenge. A 77-year-old man presented with a 2-cm firm, erythematous nodule on the chest. A punch biopsy revealed plywood-like sclerosis and spindle cells with a vaguely storiform pattern. The tumor cells were positive for CD34. Sclerotic fibroma and DFSP were considered differential diagnoses. Subsequent excisional biopsy revealed that the tumor comprised 3 different histopathological areas: classic DFSP, sclerotic fibroma-like, and giant cell fibroblastoma-like. This report highlights the importance of reevaluating the clinical context and excision for further characterization.

Identifiants

pubmed: 39293665
doi: 10.1097/DAD.0000000000002773
pii: 00000372-202410000-00007
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

675-678

Informations de copyright

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Llombart B, Sanmartín O, López-Guerrero JA, et al. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB) study with therapeutic implications. Histopathology. 2009;54:860–872.
Thway K, Noujaim J, Jones RL, et al. Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies. Ann Diagn Pathol. 2016;25:64–71.
Allen A, Ahn C, Sangüeza OP. Dermatofibrosarcoma protuberans. Dermatol Clin. 2019;37:483–488.
Diaz-Cascajo C, Weyers W, Borghi S. Sclerosing dermatofibrosarcoma protuberans. J Cutan Pathol. 1998;25:440–444.
Hattori H. Nodular sclerotic change in dermatofibrosarcoma protuberans: a potential diagnostic problem. Br J Dermatol. 2003;148:357–360.
Sabater-Marco V, Pérez-Vallés A, Berzal-Cantalejo F, et al. Sclerosing dermatofibrosarcoma protuberans (DFSP): an unusual variant with focus on the histopathologic differential diagnosis. Int J Dermatol. 2006;45:59–62.
Abdaljaleel MY, North JP. Sclerosing dermatofibrosarcoma protuberans shows significant overlap with sclerotic fibroma in both routine and immunohistochemical analysis: a potential diagnostic pitfall. Am J Dermatopathol. 2017;39:83–88.
Saggini A, Cerroni L, Balzarini P, et al. Sclerotic fibroma-like dermatofibrosarcoma protuberans with pleomorphic sarcomatous transformation: a diagnostic challenge. Am J Dermatopathol. 2021;43:315–317.
High WA, Stewart D, Essary LR, et al. Sclerotic fibroma-like change in various neoplastic and inflammatory skin lesions: is sclerotic fibroma a distinct entity? J Cutan Pathol. 2004;31:373–378.
González-Vela MC, Val-Bernal JF, González-López MA, et al. Pure sclerotic neurofibroma: a neurofibroma mimicking sclerotic fibroma. J Cutan Pathol. 2006;33:47–50.
Aiba S, Tabata N, Ishii H, et al. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34. Br J Dermatol. 1992;127:79–84.
Mahmood MN, Salama ME, Chaffins M, et al. Solitary sclerotic fibroma of skin: a possible link with pleomorphic fibroma with immunophenotypic expression for O13 (CD99) and CD34. J Cutan Pathol. 2003;30:631–636.
Rapini RP, Golitz LE. Sclerotic fibromas of the skin. J Am Acad Dermatol. 1989;20:266–271.
Metcalf JS, Maize JC, LeBoit PE. Circumscribed storiform collagenoma (sclerosing fibroma). Am J Dermatopathol. 1991;13:122–129.
Requena L, Gutiérrez J, Sánchez Yus E. Multiple sclerotic fibromas of the skin. A cutaneous marker of Cowden's disease. J Cutan Pathol. 1992;19:346–351.
Llombart B, Serra-Guillén C, Monteagudo C, et al. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management. Semin Diagn Pathol. 2013;30:13–28.
Terrier-Lacombe MJ, Guillou L, Maire G, et al. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data-a study from the French federation of cancer centers sarcoma group. Am J Surg Pathol. 2003;27:27–39.
Braswell DS, Ayoubi N, Motaparthi K, et al. Dermatofibrosarcoma protuberans with features of giant cell fibroblastoma in an adult. J Cutan Pathol. 2020;47:317–320.

Auteurs

Toru Kurimoto (T)

Department of Dermatology, Nara Prefecture General Medical Center, Nara, Japan.

Yasuhiro Mitsui (Y)

Department of Dermatology, Nara Prefecture General Medical Center, Nara, Japan.
Department of Dermatology, Nara Medical University School of Medicine, Kashihara, Japan.

Takashi Nakanishi (T)

Department of Plastic Surgery, Nara Prefecture General Medical Center, Nara, Japan.

Kohei Morita (K)

Department of Diagnostic Pathology, Nara Prefecture General Medical Center, Nara, Japan.

Eiwa Ishida (E)

Department of Diagnostic Pathology, Nara Prefecture General Medical Center, Nara, Japan.

Kohei Ogawa (K)

Department of Dermatology, Nara Medical University School of Medicine, Kashihara, Japan.

Kaori Koga (K)

Department of Pathology, Fukuoka University Hospital and School of Medicine, Fukuoka, Japan; and.

Takaya Fukumoto (T)

Fukumoto Dermatopathology Clinic, Nara, Japan.

Hideo Asada (H)

Department of Dermatology, Nara Medical University School of Medicine, Kashihara, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH